Evidence map›Paper›PMID 38757699›Full record

ArticleInfectious disorders drug targets2024

A Retrospective Study Comparing Mortality Rates between Vaccinated and Unvaccinated Kidney Transplant Recipients.

Anaam Fayyaz, Judy Pozzerle, Suresh J Antony

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Infectious disorders drug targets, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anaam FayyazInternal Medicine Resident Physician, HCA Las Palmas Del Sol Medical Center, El Paso, Texas, USA.
Judy PozzerleQuality Coordinator Transplant Services, Las Palmas Medical Center, El Paso, Texas, USA.
Suresh J AntonyClinical Prof. of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

<p>Background: With the emergence of vaccines for COVID-19, mortality and severity of disease have decreased. However, patients with certain comorbidities, such as immunosuppression, CKD, and renal transplant, still have higher mortality rates as compared to the general population. Current data suggests that the risk of developing COVID-19 among transplant patients was reported to be about 5%, which is significantly higher than the risk rate of 0.3% in the general population. Studies utilizing larger sample sizes (i.e., multiple cohorts, sites, hospitals) comparing COVID-19 outcomes among renal transplant patients with a control group are lacking. <p> Objective: The purpose of this descriptive study was to compare the mortality rate between vaccinated and unvaccinated kidney transplant recipients. <p> Methods: Participants were recruited at a community-based transplant clinic in West Texas. <p> Results: Among the group of participants who tested positive for COVID-19 between 2020 and 2022, higher mortality rates and longer hospital stays were noted among those unvaccinated (72% unvaccinated had greater than 5-day length of stay vs. 33% vaccinated). <p> Conclusion: Our study suggests that vaccination against COVID-19 decreases mortality rates in kidney transplant recipients.</p>.

Indexed as

COVID-19Kidney TransplantationTransplant RecipientsVaccinationAdultAgedCOVID-19 VaccinesFemaleHumansLength of StayMaleMiddle AgedRetrospective StudiesSARS-CoV-2TexasUnvaccinated PersonsCOVID-19 VaccinesCOVID-19emerging diseasesinfectious diseasekidneynephrologytransplantvaccinations.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.